FDA denies Denali's Takeda-partnered Alzheimer's drug from entering clinic

[cafead]

via The FDA has thrown Denali Therapeutics' Alzheimer's med into murky waters with a clinical hold before the drug even enters human trials. The move also impacts Takeda, which just last month moved forward on the pair's 2018 deal by opting to co-develop the drug.

article source